C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
about
Aortic stenosis: An updateRosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosisBiomarkers in Cardiology - Part 2: In Coronary Heart Disease, Valve Disease and Special SituationsC-reactive protein in aortic valve diseaseC-reactive protein in degenerative aortic valve stenosisCritical appraisal of C-reactive protein throughout the spectrum of cardiovascular diseaseMechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.Linking soluble vascular adhesion molecule-1 level to calcific aortic stenosis in patients with coronary artery diseasePorphyromonas gingivalis in periodontal pockets and heart valvesEthnic differences in aortic valve thickness and related clinical factors.Associations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis.Insights into the use of biomarkers in calcific aortic valve diseaseCalcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts.C-reactive protein and subclinical cardiovascular disease among African-Americans: (the Jackson Heart Study).Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valveTissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statinsDoes diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves?Is it time for medical therapy for aortic valve disease?Association of the C-Reactive Protein Gene (CRP) rs1205 C>T Polymorphism with Aortic Valve Calcification in Patients with Aortic Stenosis.Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology.Circulating CD14(+) monocytes in patients with aortic stenosis.Mast cells in human stenotic aortic valves are associated with the severity of stenosisEnzymatically Modified Low-Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease.New concepts in valvular hemodynamics: implications for diagnosis and treatment of aortic stenosis.Impact of clinical and procedural factors upon C reactive protein dynamics following transcatheter aortic valve implantation.New cardiovascular biomarkers: clinical implications in patients with valvular heart disease.Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive?Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.Increased risk of aortic valve stenosis in patients with psoriasis: a nationwide cohort study.New considerations in the assessment of aortic stenosis.Biomarkers of Calcific Aortic Valve Disease.Removal of the left atrium and left ventricle tumour: a case reportIncreased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation.Intermediate CD14++CD16+ monocytes decline after transcatheter aortic valve replacement and correlate with functional capacity and left ventricular systolic function.Persistent endothelial dysfunction in calcified aortic stenosis beyond valve replacement surgery.Severe Aortic Valve Stenosis in Adults is Associated with Increased Levels of Circulating Intermediate Monocytes.Increased serum chemerin level to predict early onset of aortic valve stenosis.High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis.
P2860
Q24569646-14B02C16-1A21-4D79-83B4-77749E9394F2Q24595023-43D945BB-C46F-4330-BFB6-6483E72EFAD3Q28087152-188D0102-A665-40FB-A9EC-3ECF8F86CE10Q28200692-629D67A2-C093-45A2-988E-C92ECF838B63Q28219092-480E5BE2-A725-448C-8EF4-36CCF5C2E749Q28219483-92EF0465-F05F-455E-9B28-674ECF4E198EQ33589249-0B927182-ED37-47BE-AA24-20E4AB02CCF7Q33595740-92EC70F1-F315-49DF-A172-DD5B90517C2BQ33779132-89F11A2B-ACC9-4849-AB33-28CC61AD9C44Q33781161-1CFB4368-1797-4481-A234-2A615C7B6A08Q33788258-A37874AE-1794-4CD6-921D-AB1E44D14FF4Q34139677-708F700B-7116-44BD-B95F-459E37C8CC34Q35154908-EECBF55B-77D6-4238-A2F0-3BC8AA0120FDQ35158958-59B6A7AA-12D6-4D27-8463-5D42FDF48E99Q35535837-29BE03B3-3732-49F5-98AE-696CC1FE2E6CQ35584233-69BA9377-1FF8-4B6A-B52F-B9D3FACC8DC9Q35771582-00C8BCB4-A459-4469-A381-EBAE961411C3Q35904561-90AA7CBC-2119-471A-A58A-31D653C7581BQ35925688-6A97FCAF-53BA-4868-9CD9-EE99820769E7Q36247336-0D8FE9AB-4D15-43C8-8BFB-21E9328485ECQ36546306-468C8E5B-A616-49B9-9D82-76BB5FD35EACQ36578461-A7DD0EC4-EA34-4338-B843-21EBB1FDFEBAQ36665953-4D7AD8D8-0FEA-4C3D-8F44-EA979269761FQ36836028-20D65FA0-89CE-4F1E-8BB7-93741FB54510Q36969076-C1A6F33C-A915-4CC9-AC12-1F8AA26E393BQ37121184-36193618-60B9-4BAD-B8C6-BC2DC75C7682Q37230379-7A9BD0F5-B52E-44DA-8C9D-538FF058D419Q37309166-6011A2D9-027B-4A6F-A4C9-1346854CFCDAQ37591706-A86D3E99-958A-43F7-A6B2-0E487034B6DDQ38261649-AE202BF3-E1D6-4F08-9777-F1952A798858Q38414295-4707E374-8248-4D4A-91BC-6076A1E0C027Q38638916-DB0EBB35-0473-4CFF-BACC-B23EAFF34E1BQ38762609-AB3C73AC-1763-44A5-B198-FDA7D2AF7F88Q40417688-C2304AE4-1625-433A-A9E8-C7B585A5928CQ40571558-14D0FC06-FE97-44D2-812F-670C8EF7BC93Q41501489-1D92CF35-9B82-4CF1-9291-1E8E7672F9FBQ42829510-F9B07DBE-4AD2-4DA9-A9A8-10D714830229Q48342319-D4722F7E-0089-42FF-B4A2-773ADA0C8552Q48508496-60B3F7ED-B26D-4ECF-AEA1-9AA256B765FEQ48540294-327C491C-B948-4594-A63E-28DAF7F360EC
P2860
C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2001
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
@en
C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
@nl
type
label
C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
@en
C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
@nl
prefLabel
C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
@en
C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
@nl
P2093
P1476
C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
@en
P2093
Pietroiusti A
P304
P356
10.1016/S0735-1097(01)01484-X
P407
P577
2001-10-01T00:00:00Z